Search Results

You are looking at 1 - 10 of 312 items for :

Clear All
Full access

Donald A. Podoloff, Ranjana H. Advani, Craig Allred, Al B. Benson III, Elizabeth Brown, Harold J. Burstein, Robert W. Carlson, R. Edward Coleman, Myron S. Czuczman, Dominique Delbeke, Stephen B. Edge, David S. Ettinger, Frederic W. Grannis Jr., Bruce E. Hillner, John M. Hoffman, Krystyna Kiel, Ritsuko Komaki, Steven M. Larson, David A. Mankoff, Kenneth E. Rosenzweig, John M. Skibber, Joachim Yahalom, JQ Michael Yu and Andrew D. Zelenetz

-line to the NCCN Clinical Practice Guidelines in Oncology at www.nccn.org .) This supplement summarizes the proceedings of this meeting. The term PET scan refers to either a PET scan or PET/computed tomography (CT) scan, unless otherwise specified. In

Full access

Sukru Mehmet Erturk and Annick D. Van den Abbeele

Allred C . NCCN Task Force Report: PET/CT Scanning in Cancer . J Natl Compr Canc Netw 2007 ; 5 ( Suppl 1 ): S1 – 22 . 4. Seam P Juweid ME Cheson BD . The role of FDG-PET scans in patients with lymphoma . Blood 2007 ; 110 : 3507 – 3516

Full access

Benjamin R. Roman, Snehal G. Patel, Marilene B. Wang, Anna M. Pou, F. Christopher Holsinger, David Myssiorek, David Goldenberg, Samuel Swisher-McClure, Alexander Lin, Jatin P. Shah and Judy A. Shea

membership profile. The survey instrument included physician demographic and practice characteristics items, reported use of surveillance PET/CT scans after a clinical scenario, and familiarity with guideline recommendations for surveillance imaging. Survey

Full access

Raymond Elsoueidi, Jessica Craig, Hesham Mourad and Elie M. Richa

( Figure 3 ). The patient received a total of 21 cycles of FOLFOX, but then his total bilirubin started to increase and he developed ascites. At that time, a CT scan of the abdomen showed splenomegaly, ascites, and cirrhotic liver, and FOLFOX was

Full access

James M. Cleary, Scott Rodig, Paul M. Barr, Atul B. Shinagare, Jeffrey W. Clark, Geoffrey I. Shapiro and Philippe Armand

347 U/L. On the experimental protocol, the patient was treated with crizotinib, 250 mg twice a day. Crizotinib was well tolerated and no signs were seen of tumor lysis. Symptomatic improvement was seen within 3 days, and a restaging PET/CT scan

Full access

Vijaya Raj Bhatt, R. Gregory Bociek, Ji Yuan, Kai Fu, Timothy C. Greiner, Bhavana J. Dave, Sandeep K. Rajan and James O. Armitage

rearrangement of BCL6 but not BCL2 or CMYC (see Appendix 1, available online, in this article, at JNCCN.org ). Integrated 18 F-fluorodeoxyglucose PET/CT scan of the skull to mid-thigh showed multiple enlarged and hypermetabolic cervical, mediastinal

Full access

Bernardo H. L. Goulart, Mark E. Bensink, David G. Mummy and Scott D. Ramsey

consist of follow-up chest CT scans, followed by chest radiographs and PET/CT scans. Most subsequent procedures consist of bronchoscopies (with and without biopsies), followed by thoracotomies and percutaneous biopsies. Screen-detected lung cancer cases

Full access

James S. Blachly, Gerard Lozanski, David M. Lucas, Michael R. Grever, Kari Kendra and Leslie A. Andritsos

deeper lesion was approximately 1.8 cm in maximum diameter, was present in the subcutis, with a distance of Figure 1 (A) PET/CT scan, (B) MRI of local melanoma recurrence, and (C) resolution of FDG avidity in arm and spleen. 0.8 mm to the

Full access

Douglas Arenberg and Ella A. Kazerooni

In November 2010, the National Lung Cancer Screening Trial (NLST) was halted by the NIH, with the compelling news that CT reduced lung cancer mortality by 20% and all-cause mortality by 7% when 3 annual low-dose helical CT scans were performed in

Full access

Pelin Cinar and Andrew H. Ko

abdominal ultrasound that revealed a 1.7-cm pancreatic head mass. Abdominal CT scan confirmed a hypoattenuating mass localized at the junction of the superior pancreatic head and neck; these findings were thought to represent a possible pancreatic pseudocyst